Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.50 |
| ▸ | GAA | P10253 | 6/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | GLA | P06280 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.50 |
| ▸ | IKBKB | O14920 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30272856 | 0.81 | ALDH1A1 (0.51) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL164735 | 0.81 | CA2 (0.59) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL329215 | 0.81 | ALDH1A1 (0.51) | ALDH1A1KDM4EGAAKMT2AGLA | |
| Methane SCHEMBL28725834 | 0.80 | CA2 (0.58) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL642753 | 0.80 | CA2 (0.58) | ALDH1A1KDM4EGAAKMT2AGLA | |
| Acridine SCHEMBL28003717 | 0.80 | CA2 (0.58) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL329214 | 0.79 | ALDH1A1 (0.53) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL1051623 | 0.78 | ALDH1A1 (0.51) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL29021903 | 0.75 | ALDH1A1 (0.49) | ALDH1A1KDM4EGAAKMT2AGLA | |
| SCHEMBL154847 | 0.74 | ALDH1A1 (0.64) | ALDH1A1KDM4EGAAKMT2AGLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 73 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6025149-A | CHEAPER, NONINVASIVE QUANTITATIVE ANALYSIS OF URINE SAMPLE FROM PREGNANT WOMAN IN SECOND OR THIRD TRIMESTER FOR HUMAN CHORIONIC GONADOTROPHIN LEVEL, COMPARING TO STANDARDS; INCREASED OR DECREASED LEVEL INDICATES RISK | YALE UNIVERSITY (US) | 2000-02-15 | — | — | US | claimed |
| US-5770176-A | CORRELATING SPECIFIC BINDING OF NUCLEIC ACID REAGENT, LIGANDS AND ANTIBODIES IN SAMPLE WITH PRESENCE OF RECEPTORS | CHIRON DIAGNOSTICS CORPORATION (US) | 1998-06-23 | — | — | US | claimed |
| US-5716853-A | ENZYME-LINKED IMMUNOSORBENT ASSAY | CHIRON DIAGNOSTICS CORPORATION (US) | 1998-02-10 | — | — | US | claimed |
| CN-115942939-A | Diastereomer ligation reagents for nucleotide probes | 布伦塔诺生物技术联合公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20170210825-A1 | MONOSPECIFIC AND MULTISPECIFIC ANTIBODIES AND METHOD OF USE | BAYER IP GMBH (US) | 2017-07-27 | — | — | US | disclosed |
| US-9624309-B2 | Monospecific and multispecific antibodies and method of use | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2017-04-18 | — | — | US | disclosed |
| EP-2532676-B1 | Protease-regulated antibody | Bayer Pharma AG (DE) | 2017-03-22 | — | — | EP | disclosed |
| CN-102585001-B | Anti-mn antibodies and methods of using same | BAYER HEALTHCARE LLC | 2014-08-27 | — | — | CN | disclosed |
| EP-1963372-B1 | ANTI-MN ANTIBODIES AND METHODS OF USING THE SAME | BAYER HEALTHCARE LLC (US) | 2013-07-03 | — | — | EP | disclosed |
| EP-2532676-A1 | Protease-regulated antibody | Bayer Pharma Aktiengesellschaft (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-20120301468-A1 | ANTI-MN ANTIBODIES AND METHODS OF USING SAME | BAYER HEALTHCARE LLC (US) | 2012-11-29 | — | — | US | disclosed |
| US-20040203072-A1 | Uncoupled collagen synthesis and degradation assays | BARNES-JEWISH HOSPITAL | 2004-10-14 | — | — | US | disclosed |
| EP-1141726-B1 | IMMUNOASSAYS TO DETECT DISEASES OR DISEASE SUSCEPTIBILITY TRAITS | CA TX INC (US) | 2004-08-04 | — | — | EP | disclosed |
| WO-2004043237-A2 | UNCOUPLED COLLAGEN SYNTHESIS AND DEGRADATION ASSAYS | BARNES-JEWISH HOSPITAL (US) | 2004-05-27 | — | — | WO | disclosed |
| EP-1141726-A1 | IMMUNOASSAYS TO DETECT DISEASES OR DISEASE SUSCEPTIBILITY TRAITS | CA*TX, Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000042436-A1 | IMMUNOASSAYS TO DETECT DISEASES OR DISEASE SUSCEPTIBILITY TRAITS | CA*TX, INC. (US) | 2000-07-20 | — | — | WO | disclosed |
| US-6025149-A | CHEAPER, NONINVASIVE QUANTITATIVE ANALYSIS OF URINE SAMPLE FROM PREGNANT WOMAN IN SECOND OR THIRD TRIMESTER FOR HUMAN CHORIONIC GONADOTROPHIN LEVEL, COMPARING TO STANDARDS; INCREASED OR DECREASED LEVEL INDICATES RISK | YALE UNIVERSITY (US) | 2000-02-15 | — | — | US | disclosed |
| US-5770176-A | CORRELATING SPECIFIC BINDING OF NUCLEIC ACID REAGENT, LIGANDS AND ANTIBODIES IN SAMPLE WITH PRESENCE OF RECEPTORS | CHIRON DIAGNOSTICS CORPORATION (US) | 1998-06-23 | — | — | US | disclosed |
| US-5716853-A | ENZYME-LINKED IMMUNOSORBENT ASSAY | CHIRON DIAGNOSTICS CORPORATION (US) | 1998-02-10 | — | — | US | disclosed |
| WO-1997003363-A1 | PRENATAL URINARY SCREENING FOR DOWN SYNDROME AND OTHER ANEUPLOIDIES | CHIRON DIAGNOSTICS CORPORATION (US) | 1997-01-30 | — | — | WO | disclosed |